NDC properties for NDC 9 51759-360
NDC item 51759036002
| NDC 9 | 51759-360 |
|---|---|
| NDC 10 | 51759-360-02 |
| NDC Item | 51759036002 |
| packaging | 2 KIT in 1 CARTON (51759-360-02) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .4 mL in 1 SYRINGE (51759-513-21) * .4 mL in 1 POUCH (65517-0002-1) |
| BLA | BLA761299 |
| Labeler | Teva Pharmaceuticals USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2025-02-28 |
| Marketing status | active |
NDC item 51759036017
| NDC 9 | 51759-360 |
|---|---|
| NDC 10 | 51759-360-17 |
| NDC Item | 51759036017 |
| packaging | 1 KIT in 1 CARTON (51759-360-17) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .4 mL in 1 SYRINGE (51759-513-21) * .4 mL in 1 POUCH (65517-0002-1) |
| BLA | BLA761299 |
| Labeler | Teva Pharmaceuticals USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2025-02-28 |
| Marketing status | active |
NDC item 82009015622
| NDC 9 | 82009-156 |
|---|---|
| NDC 10 | 82009-156-22 |
| NDC Item | 82009015622 |
| packaging | 2 KIT in 1 CARTON (82009-156-22) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY (82009-157-11) / .4 mL in 1 SYRINGE * .4 mL in 1 POUCH (65517-0002-1) |
| BLA | BLA761299 |
| Labeler | Quallent Pharmaceuticals Health LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2024-05-22 |
| Marketing status | ACTIVE |
NDC item 82009015711
| NDC 9 | 82009-157 |
|---|---|
| NDC 10 | 82009-157-11 |
| NDC Item | 82009015711 |
| packaging | 0.4 mL in 1 SYRINGE |
| packaging | 1 in 1 TRAY |
| Labeler | Quallent Pharmaceuticals Health LLC |
| Label type | HUMAN PRESCRIPTION DRUG LABEL |